Metraipolis › archive › dc_97eb8e694484

Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland — Europe PMC PPR:PPR1094515

Source
Europe PMC
Original
https://europepmc.org/article/PPR/PPR1094515
DOI
10.21203/rs.3.rs-7702834/v1
License (as archived)
solo-consultazione
Archived
2026-10-07T11:32:57.057Z
SHA-256 of the archived text
0cb49e719f2a064ebb7f18ef61c1b1f0fb42262bfa900d348e7f82019cb82345
Stable URL of this page
https://metraipolis.com/documento/dc_97eb8e694484

How to cite

Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland — Europe PMC PPR:PPR1094515 — Europe PMC, https://europepmc.org/article/PPR/PPR1094515 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_97eb8e694484 (Metraipolis archive dc_97eb8e694484, sha256 0cb49e719f2a064ebb7f18ef61c1b1f0fb42262bfa900d348e7f82019cb82345)
BibTeX
@misc{dc97eb8e694484,
  title = {Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland — Europe PMC PPR:PPR1094515},
  howpublished = {Europe PMC},
  url = {https://europepmc.org/article/PPR/PPR1094515},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_97eb8e694484; sha256 0cb49e719f2a064ebb7f18ef61c1b1f0fb42262bfa900d348e7f82019cb82345},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/PPR/PPR1094515. Agents can read the archived copy with the MCP tool read_document.